Two-dimensional transthoracic echocardiographic demonstration of reduction in fibrin content in purulent pericarditis following intrapericardial fibrinolytic agent administration

被引：0

作者：

Abdelsalam, Mahmoud ^{[1
]}

Nathanial, Cyril ^{[2
]}

Elmarzouky, Zeyad ^{[3
]}

Dulal, Subash ^{[3
]}

Habib, Usama ^{[1
]}

Ahmed, Maram ^{[4
]}

Ashiq, Amir ^{[1
]}

Nanda, Navin ^{[3
]}

机构：

[1] Temple Univ, Dept Med, Ctonemaugh Mem Med Ctr, Johnstown, PA 15905 USA

[2] Conemaugh Mem Med Ctr, Div Cardiol, Dept Med, Johnstown, PA USA

[3] Univ Alabama Birmingham, Div Cardiol, Dept Med, Birmingham, AL USA

[4] Ain Shams Univ, Fac Med, Cairo, Egypt

来源：

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES | 2022年 / 39卷 / 01期

关键词：

constrictive pericarditis; fibrin; fibrinolytic agent; intrapericardial; pericarditis; purulent pericarditis; two-dimensional transthoracic echocardiography; STREPTOKINASE; MANAGEMENT; DIAGNOSIS;

D O I：

10.1111/echo.15282

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We describe an adult patient who presented with purulent pericarditis (PP) in whom two-dimensional transthoracic echocardiography demonstrated a marked decrease in the area of the right ventricular (RV) wall together with the overlying fibrin following intrapericardial administration of a fibrinolytic agent. Documentation of this decrease by measurements performed and illustrated on two-dimensional images has not been reported previously in an adult patient with PP, to the best of our knowledge.

引用

页码：146 / 148

页数：3

共 23 条

[1]

Abdelnabi Mahmoud, 2021, Proc (Bayl Univ Med Cent), V34, P498, DOI 10.1080/08998280.2021.1889297

[2] 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases [J].

Adler, Yehuda ;

Charron, Philippe ;

Imazio, Massimo ;

Badano, Luigi ;

Baron-Esquivias, Gonzalo ;

Bogaert, Jan ;

Brucato, Antonio ;

Gueret, Pascal ;

Klingel, Karin ;

Lionis, Christos ;

Maisch, Bernhard ;

Mayosi, Bongani ;

Pavie, Alain ;

Ristic, Arsen D. ;

Tenas, Manel Sabate ;

Seferovic, Petar ;

Swedberg, Karl ;

Tomkowski, Witold .

REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (12) :1126-1126

[3] Clinical review: Intrapericardial fibrinolysis in management of purulent pericarditis [J].

Augustin, Pascal ;

Desmard, Mathieu ;

Mordant, Pierre ;

Lasocki, Sigismond ;

Maury, Jean-Michel ;

Heming, Nicholas ;

Montravers, Philippe .

CRITICAL CARE, 2011, 15 (02)

[4]

Bigham Michael T, 2008, Pediatr Crit Care Med, V9, pe1, DOI 10.1097/01.PCC.0000298765.02358.07

[5] Purulent pericarditis in childhood:: Ten years of experience [J].

Cakir, Ö ;

Gurkan, F ;

Balci, AE ;

Eren, N ;

Dikici, B .

JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (10) :1404-1408

[6]

CROSS JH, 1989, BRIT HEART J, V62, P217

[7]

Cui Han-bin, 2005, Chinese Medical Sciences Journal, V20, P5

[8] Intrapericardial fibrinolysis: A useful treatment in the management of purulent pericarditis [J].

Defouilloy, C ;

Meyer, G ;

Slama, M ;

Galy, C ;

Verhaeghe, P ;

Touati, G ;

Ossart, M .

INTENSIVE CARE MEDICINE, 1997, 23 (01) :117-118

[9] Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series [J].

Dybowska, Malgorzata ;

Szturmowicz, Monika ;

Opoka, Lucyna ;

Rudzinski, Piotr ;

Tomkowski, Witold .

BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)

[10] Intrapericardial fibrinolysis in purulent pericarditis—case report [J].

Dybowska M. ;

Kazanecka B. ;

Kuca P. ;

Burakowski J. ;

Czajka C. ;

Grzegorczyk F. ;

Gralec R. ;

Tomkowski W. .

International Journal of Emergency Medicine, 2015, 8 (1)

← 1 2 3 →